Chart, page-19413

Shares on Issue amount is a big contributing factor here. At 1/10 our shares theyve maintained what is a limited dilution model at this point.
Our dilution here hasnt helped the SP but if BRN gets to 20B market cap then the dilution means nil.
Full disclosure - I hold WBT, but its been a fascinating journey for these 2 stocks.
Does WBT have some massive future dilution events to reach its goals?
Ya have to remember that it buzzed up to$11.50 first listed year so many would be in the red here from 2011 - 2013 if still holding.
I dont contribute on its forums but I do chart it. Theres 100% move to ATH.
BRN has over 300% to its ATH.
Both companies are in the right space, WBT should on paper see more volatility in SP given its SOI but how high can it go?
To answer your question IMO BRN is cheap even if you use only Patent value & current licenses value to measure - True share dollar value wont be realised financially until revenue kicks in and fundamentals start to line up. 2024 - 2025. Theres many SP kickers like a Nasdaq listing, product release announcements, further patents and continued staff growth/ office openings, that will be realised at some point.
Which stock has greater capacity for large SP - BRN in my opinion. The shear volume of use cases expanding with each AKD model is exponential and limitless. The IP model is extremely profitable once its established. When revenue hits, I think jumps will occur in 9 figure lumps, not as weve experienced to date. If ONLY the dozen or more partners sign licenses, that a dozen price sensitive announcements. That would put us up there with WBT SP in my opinion. So its just a waiting game here.